The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
Open accessAbstract
BACKGROUND: Although radiologic size criteria (Milan/University of California, San Francisco [UCSF]) have led to improved outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC), recurrence remains a significant challenge. We analyzed our 30-year experience with LT for HCC to identify predictors of recurrence. STUDY DESIGN: A novel clinicopathologic risk score and prognostic nomogram predicting post-transplant HCC recurrence was developed from a multivariate competing-risk Cox regression analysis of 865 LT recipients with HCC between 1984 and 2013. RESULTS: Overall patient and recurrence-free survivals were 83%, 68%, 60% and 79%, 63%, and 56% at 1-, 3-, and 5-years, respectively. Hepatocellular carcinoma recurred in 117 recipients, with a median time to recurrence of 15 months, involving the lungs (59%), abdomen/pelvis (38%), liver (35%), bone (28%), pleura/mediastinum (12%), and brain (5%). Multivariate predictors of recurrence included tumor grade/differentiation (G4/poor diff hazard ratio [HR] 8.86; G2-3/mod-poor diff HR 2.56), macrovascular (HR 7.82) and microvascular (HR 2.42) invasion, nondownstaged tumors outside Milan criteria (HR 3.02), nonincidental tumors with radiographic maximum diameter ≥ 5 cm (HR 2.71) and <5 cm (HR 1.55), and pretransplant neutrophil-to-lymphocyte ratio (HR 1.77 per log unit), maximum alpha fetoprotein (HR 1.21 per log unit), and total cholesterol (HR 1.14 per SD). A pretransplantation model incorporating only known radiographic and laboratory parameters had improved accuracy in predicting HCC recurrence (C statistic 0.79) compared with both Milan (C statistic 0.64) and UCSF (C statistic 0.64) criteria alone. A novel clinicopathologic prognostic nomogram included explant pathology and had an excellent ability to predict post-transplant recurrence (C statistic 0.85). CONCLUSIONS: In the largest single-institution experience with LT for HCC, excellent long-term survival was achieved. Incorporation of routine pretransplantation biomarkers to existing radiographic size criteria significantly improves the ability to predict post-transplant recurrence, and should be considered in recipient selection. A novel clinicopathologic prognostic nomogram accurately predicts HCC recurrence after LT and may guide frequency of post-transplantation surveillance and adjuvant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences [RETRACTED]
Zheng, S.-S., Xu, X., Wu, J., Chen, J., Wang, W.-L., Zhang, M., Liang, T.-B., & Wu, L.-M. (2008) · Transplantation · doi:10.1097/tp.0b013e31816b67e4 · Cited by 452
RetractedWang, G., Yang, Y., Li, H., Zhang, J., Jiang, N., Li, M., Zhu, H., Zhang, Q., & Chen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025295 · Cited by 87
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Model for end-stage liver disease (MELD) and allocation of donor livers
Wiesner, R., Edwards, E., Freeman, R., Harper, A., Kim, R., Kamath, P., Kremers, W., Lake, J., Howard, T., Merion, R. M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50016 · Cited by 2,528
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Mazzaferro, V., Llovet, J. M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Camerini, T., Roayaie, S., Schwartz, M. E., Grazi, G. L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70284-5 · Cited by 2,045
American Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Duvoux, C., Roudot–Thoraval, F., Decaens, T., Pessione, F., Badran, H., Piardi, T., Francoz, C., Compagnon, P., Vanlemmens, C., Dumortier, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.052 · Cited by 955
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., & Keeling, N. J. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20329 · Cited by 894
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
IWATSUKI, S., STARZL, T. E., SHEAHAN, D. G., YOKOYAMA, I., DEMETRIS, A. J., TODO, S., TZAKIS, A. G., VAN THIEL, D. H., CARR, B., SELBY, R., et al. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00005 · Cited by 669
Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction
Wolbers, M., Koller, M. T., Witteman, J. C. M., & Steyerberg, E. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a39056 · Cited by 625
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
Yao, F. Y., Kerlan, R. K., Hirose, R., Davern, T. J., Bass, N. M., Feng, S., Peters, M., Terrault, N., Freise, C. E., Ascher, N. L., et al. (2008) · Hepatology · doi:10.1002/hep.22412 · Cited by 513
Mazzaferro, V., Battiston, C., Perrone, S., Pulvirenti, A., Regalia, E., Romito, R., Sarli, D., Schiavo, M., Garbagnati, F., Marchianò, A., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143301.56154.95 · Cited by 491
Hepatocellular Carcinoma: Current Management and Perspectives for the Future
Rahbari, N. N., Mehrabi, A., Mollberg, N. M., Müller, S. A., Koch, M., Büchler, M. W., & Weitz, J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820d944f · Cited by 453
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.017 · Cited by 448
Duffy, J. P., Vardanian, A., Benjamin, E., Watson, M., Farmer, D. G., Ghobrial, R. M., Lipshutz, G., Yersiz, H., Lu, D. S. K., Lassman, C., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148c704 · Cited by 445
Self-citationHalazun, K. J., Aldoori, A., Malik, H. Z., Al-Mukhtar, A., Prasad, K. R., Toogood, G. J., & Lodge, J. P. A. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.02.014 · Cited by 444
Otto, G., Herber, S., Heise, M., Lohse, A. W., Mönch, C., Bittinger, F., Hoppe-Lotichius, M., Schuchmann, M., Victor, A., & Pitton, M. (2006) · Liver Transplantation · doi:10.1002/lt.20837 · Cited by 410
Gomez, D., Farid, S., Malik, H. Z., Young, A. L., Toogood, G. J., Lodge, J. P. A., & Prasad, K. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9552-6 · Cited by 402
Halazun, K. J., Hardy, M. A., Rana, A. A., Woodland, D. C., Luyten, E. J., Mahadev, S., Witkowski, P., Siegel, A. B., Brown, R. S., & Emond, J. C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a77e59 · Cited by 401
Todo, S., & Furukawa, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137129.98894.42 · Cited by 380
Ravaioli, M., Grazi, G. L., Piscaglia, F., Trevisani, F., Cescon, M., Ercolani, G., Vivarelli, M., Golfieri, R., D’Errico Grigioni, A., Panzini, I., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02409.x · Cited by 363
Lu, D. S. K., Yu, N. C., Raman, S. S., Lassman, C., Tong, M. J., Britten, C., Durazo, F., Saab, S., Han, S., Finn, R., et al. (2005) · Hepatology · doi:10.1002/hep.20688 · Cited by 355
Self-citationChapman, W. C., Majella Doyle, M. B., Stuart, J. E., Vachharajani, N., Crippin, J. S., Anderson, C. D., Lowell, J. A., Shenoy, S., Darcy, M. D., & Brown, D. B. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31818a07d4 · Cited by 304
Davila, J. A., Henderson, L., Kramer, J. R., Kanwal, F., Richardson, P. A., Duan, Z., & El-Serag, H. B. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-2-201101180-00006 · Cited by 299
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Hameed, B., Mehta, N., Sapisochin, G., Roberts, J. P., & Yao, F. Y. (2014) · Liver Transplantation · doi:10.1002/lt.23904 · Cited by 279
Millonig, G., Graziadei, I. W., Freund, M. C., Jaschke, W. R., Stadlmann, S., Ladurner, R., Margreiter, R., & Vogel, W. (2007) · Liver Transplantation · doi:10.1002/lt.21033 · Cited by 257
Shim, J. H., Jun, M.-J., Han, S., Lee, Y.-J., Lee, S.-G., Kim, K. M., Lim, Y.-S., & Lee, H. C. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000747 · Cited by 235
Decaens, T., Roudot‐Thoraval, F., Bresson‐Hadni, S., Meyer, C., Gugenheim, J., Durand, F., Bernard, P., Boillot, O., Boudjema, K., Calmus, Y., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20418 · Cited by 222
Pawlik, T. M., Gleisner, A. L., Anders, R. A., Assumpcao, L., Maley, W., & Choti, M. A. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000250420.73854.ad · Cited by 203
Agopian, V. G., Petrowsky, H., Kaldas, F. M., Zarrinpar, A., Farmer, D. G., Yersiz, H., Holt, C., Harlander-Locke, M., Hong, J. C., Rana, A. R., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a15db4 · Cited by 196
Self-citationBerry, K., & Ioannou, G. N. (2013) · Liver Transplantation · doi:10.1002/lt.23652 · Cited by 171
Merani, S., Majno, P., Kneteman, N. M., Berney, T., Morel, P., Mentha, G., & Toso, C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.040 · Cited by 170
OPTN/SRTR 2011 Annual Data Report: Liver
Kim, W. R., Stock, P. G., Smith, J. M., Heimbach, J. K., Skeans, M. A., Edwards, E. B., Harper, A. M., Snyder, J. J., Israni, A. K., & Kasiske, B. L. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12021 · Cited by 162
de Luna, W., Sze, D. Y., Ahmed, A., Ha, B., Ayoub, W. S., Keeffe, E. B., Cooper, A. D., Esquivel, C. O., & Nguyen, M. H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02576.x · Cited by 146
Surveillance for hepatocellular carcinoma: in whom and how?
El‐Serag, H. B., & Davila, J. A. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10385964 · Cited by 139
Porrett, P. M., Peterman, H., Rosen, M. A., Sonnad, S. S., Soulen, M. C., Markmann, J. F., Shaked, A. A., Furth, E. E., Reddy, K. R., & Olthoff, K. M. (2006) · Liver Transplantation · doi:10.1002/lt.20636 · Cited by 137
Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation
Heckman, J. T., DeVera, M., Marsh, J. W., Fontes, P., Amesur, N. B., Holloway, S. E., Nalesnik, M. A., Geller, D. A., Steel, J. L., & Gamblin, T. C. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0071-3 · Cited by 136
Cho, C. S., Gönen, M., Shia, J., Kattan, M. W., Klimstra, D. S., Jarnagin, W. R., D'Angelica, M. I., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.031 · Cited by 133
Starzl, T. E. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(02)01498-9 · Cited by 83
Tsochatzis, E. A., Garcovich, M., Marelli, L., Papastergiou, V., Fatourou, E. M., Rodríguez‐Perálvarez, M., Germani, G., Davies, N., Yu, D., Luong, T. V., et al. (2013) · Liver International · doi:10.1111/liv.12144 · Cited by 63
Lei, J., Wang, W., & Yan, L. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2229-y · Cited by 58
Moreno, P., Jaurrieta, E., Figueras, J., et al. (1995) · PubMed · Cited by 41
Cited by
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[251 ,252] Because the two most common sites of posttrans-plant recurrence are the lung ( ∼ 40”
Self-citationLiver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Sapisochin, G., & Bruix, J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.193 · Cited by 436
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Erstad, D. J., & Tanabe, K. K. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07227-9 · Cited by 428
Mehta, N., Heimbach, J., Harnois, D. M., Sapisochin, G., Dodge, J. L., Lee, D., Burns, J. M., Sanchez, W., Greig, P. D., Grant, D. R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5116 · Cited by 398
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Chan, Y.-T., Zhang, C., Wu, J., Lu, P., Xu, L., Yuan, H., Feng, Y., Chen, Z.-S., & Wang, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02101-z · Cited by 281
Metadata
- Authors
- Agopian, V. G., Harlander-Locke, M., Zarrinpar, A., Kaldas, F. M., Farmer, D. G., Yersiz, H., Finn, R. S., Tong, M., Hiatt, J. R., & Busuttil, R. W.
- Venue
- Journal of the American College of Surgeons
- Published
- 2015-04
- Volume
- 220
- Issue
- 4
- Pages
- 416-427
- ISSN
- 1072-7515 (ISSN-L)
- OpenAlex
- W2093057571
- Cited by
- 252
- References
- 48
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.